267 related articles for article (PubMed ID: 28035410)
1. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.
Wang XH; Xie X; Luo XG; Shang H; He ZY
Mol Med Rep; 2017 Feb; 15(2):768-776. PubMed ID: 28035410
[TBL] [Abstract][Full Text] [Related]
2. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.
Carmo MR; Menezes AP; Nunes AC; Pliássova A; Rolo AP; Palmeira CM; Cunha RA; Canas PM; Andrade GM
Neuropharmacology; 2014 Jun; 81():142-52. PubMed ID: 24508709
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats.
Chen S; Ma Q; Krafft PR; Chen Y; Tang J; Zhang J; Zhang JH
Crit Care Med; 2013 Dec; 41(12):e466-74. PubMed ID: 23963136
[TBL] [Abstract][Full Text] [Related]
4. Brilliant Blue G, But Not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease.
Ferrazoli EG; de Souza HD; Nascimento IC; Oliveira-Giacomelli Á; Schwindt TT; Britto LR; Ulrich H
Cell Transplant; 2017 Apr; 26(4):669-677. PubMed ID: 28403913
[TBL] [Abstract][Full Text] [Related]
5. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
6. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
Ryu JK; Jantaratnotai N; Serrano-Perez MC; McGeer PL; McLarnon JG
J Neuropathol Exp Neurol; 2011 Jan; 70(1):13-22. PubMed ID: 21157381
[TBL] [Abstract][Full Text] [Related]
7. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
[TBL] [Abstract][Full Text] [Related]
8. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses.
Chu YX; Zhang Y; Zhang YQ; Zhao ZQ
Brain Behav Immun; 2010 Oct; 24(7):1176-89. PubMed ID: 20554014
[TBL] [Abstract][Full Text] [Related]
9. A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) model of depression in mice.
Farooq RK; Tanti A; Ainouche S; Roger S; Belzung C; Camus V
Psychoneuroendocrinology; 2018 Nov; 97():120-130. PubMed ID: 30015007
[TBL] [Abstract][Full Text] [Related]
10. Microglial P2X₇ receptor in the hypothalamic paraventricular nuclei contributes to sympathoexcitatory responses in acute myocardial infarction rat.
Du D; Jiang M; Liu M; Wang J; Xia C; Guan R; Shen L; Ji Y; Zhu D
Neurosci Lett; 2015 Feb; 587():22-8. PubMed ID: 25524407
[TBL] [Abstract][Full Text] [Related]
11. Brilliant Blue G protects against photoreceptor injury in a murine endotoxin-induced uveitis model.
Sakamoto K; Inukai M; Mori A; Nakahara T
Exp Eye Res; 2018 Dec; 177():45-49. PubMed ID: 30063882
[TBL] [Abstract][Full Text] [Related]
12. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.
He D; Huang B; Fu S; Li Y; Ran X; Liu Y; Chen G; Liu J; Liu D
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065205
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor blockade prevents preterm birth and perinatal brain injury in a mouse model of intrauterine inflammation.
Tsimis ME; Lei J; Rosenzweig JM; Arif H; Shabi Y; Alshehri W; Talbot CC; Baig-Ward KM; Segars J; Graham EM; Burd I
Biol Reprod; 2017 Aug; 97(2):230-239. PubMed ID: 29044426
[TBL] [Abstract][Full Text] [Related]
14. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
Jamali-Raeufy N; Mojarrab Z; Baluchnejadmojarad T; Roghani M; Fahanik-Babaei J; Goudarzi M
Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
[TBL] [Abstract][Full Text] [Related]
15. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
16. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats.
Wang YC; Cui Y; Cui JZ; Sun LQ; Cui CM; Zhang HA; Zhu HX; Li R; Tian YX; Gao JL
Mol Med Rep; 2015 Aug; 12(2):2149-54. PubMed ID: 25873133
[TBL] [Abstract][Full Text] [Related]
18. The impact of P2X7 receptor antagonist, brilliant blue G on graft-versus-host disease in mice after allogeneic hematopoietic stem cell transplantation.
Zhong X; Zhu F; Qiao J; Zhao K; Zhu S; Zeng L; Chen X; Xu K
Cell Immunol; 2016 Dec; 310():71-77. PubMed ID: 27544305
[TBL] [Abstract][Full Text] [Related]
19. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
[TBL] [Abstract][Full Text] [Related]
20. P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway.
Fang J; Chen X; Zhang L; Chen J; Liang Y; Li X; Xiang J; Wang L; Guo G; Zhang B; Zhang W
Int J Biochem Cell Biol; 2013 Jun; 45(6):1109-20. PubMed ID: 23523696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
